{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "1502182", "DateCompleted": {"Year": "1992", "Month": "09", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "01"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0027-8424", "JournalIssue": {"Volume": "89", "Issue": "16", "PubDate": {"Year": "1992", "Month": "Aug", "Day": "15"}}, "Title": "Proceedings of the National Academy of Sciences of the United States of America", "ISOAbbreviation": "Proc Natl Acad Sci U S A"}, "ArticleTitle": "Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.", "Pagination": {"StartPage": "7674", "EndPage": "7677", "MedlinePgn": "7674-7"}, "Abstract": {"AbstractText": ["We have recently shown that nitric oxide or authentic endothelium-derived relaxing factor generated in a biologic system reacts in the presence of specific protein thiols to form S-nitrosoprotein derivatives that have endothelium-derived relaxing factor-like properties. The single free cysteine of serum albumin, Cys-34, is particularly reactive toward nitrogen oxides (most likely nitrosonium ion) under physiologic conditions, primarily because of its anomalously low pK; given its abundance in plasma, where it accounts for approximately 0.5 mM thiol, we hypothesized that this plasma protein serves as a reservoir for nitric oxide produced by the endothelial cell. To test this hypothesis, we developed a methodology, which involves UV photolytic cleavage of the S--NO bond before reaction with ozone for chemiluminescence detection, with which to measure free nitric oxide, S-nitrosothiols, and S-nitrosoproteins in biologic systems. We found that human plasma contains approximately 7 microM S-nitrosothiols, of which 96% are S-nitrosoproteins, 82% of which is accounted for by S-nitroso-serum albumin. By contrast, plasma levels of free nitric oxide are only in the 3-nM range. In rabbits, plasma S-nitrosothiols are present at approximately 1 microM; 60 min after administration of NG-monomethyl-L-arginine at 50 mg/ml, a selective and potent inhibitor of nitric oxide synthetases, S-nitrosothiols decreased by approximately 40% (greater than 95% of which were accounted for by S-nitrosoproteins, and approximately 80% of which was S-nitroso-serum albumin); this decrease was accompanied by a concomitant increase in mean arterial blood pressure of 22%. These data suggest that naturally produced nitric oxide circulates in plasma primarily complexed in S-nitrosothiol species, principal among which is S-nitroso-serum albumin. This abundant, relatively long-lived adduct likely serves as a reservoir with which plasma levels of highly reactive, short-lived free nitric oxide can be regulated for the maintenance of vascular tone."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Harvard University, Cambridge, MA 02138."}], "Identifier": [], "LastName": "Stamler", "ForeName": "J S", "Initials": "JS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jaraki", "ForeName": "O", "Initials": "O"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Osborne", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Simon", "ForeName": "D I", "Initials": "DI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Keaney", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Vita", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Singel", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Valeri", "ForeName": "C R", "Initials": "CR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Loscalzo", "ForeName": "J", "Initials": "J"}], "GrantList": [{"GrantID": "HL40411", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL43344", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K08HL02582", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Proc Natl Acad Sci U S A", "NlmUniqueID": "7505876", "ISSNLinking": "0027-8424"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Nitroso Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Serum Albumin"}, {"RegistryNumber": "27JT06E6GR", "NameOfSubstance": "omega-N-Methylarginine"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "94ZLA3W45F", "NameOfSubstance": "Arginine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Arginine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": [], "DescriptorName": "Luminescent Measurements"}, {"QualifierName": ["blood"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["blood"], "DescriptorName": "Nitroso Compounds"}, {"QualifierName": [], "DescriptorName": "Photolysis"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Rabbits"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serum Albumin"}, {"QualifierName": [], "DescriptorName": "omega-N-Methylarginine"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Analyst. 1976 Sep;101(1206):742-8", "ArticleIdList": ["970656"]}, {"Citation": "Nature. 1980 Nov 27;288(5789):373-6", "ArticleIdList": ["6253831"]}, {"Citation": "Anal Chem. 1992 Apr 1;64(7):779-85", "ArticleIdList": ["1524223"]}, {"Citation": "Free Radic Res Commun. 1991;14(2):145-55", "ArticleIdList": ["1648020"]}, {"Citation": "Free Radic Res Commun. 1990;11(1-3):167-78", "ArticleIdList": ["1963618"]}, {"Citation": "N Engl J Med. 1991 May 30;324(22):1539-47", "ArticleIdList": ["2027358"]}, {"Citation": "Circ Res. 1990 Jun;66(6):1561-75", "ArticleIdList": ["2160870"]}, {"Citation": "Am J Physiol. 1990 Apr;258(4 Pt 2):H1250-4", "ArticleIdList": ["2331014"]}, {"Citation": "Proc Natl Acad Sci U S A. 1989 May;86(9):3375-8", "ArticleIdList": ["2497467"]}, {"Citation": "Biochem Pharmacol. 1989 Jun 1;38(11):1709-15", "ArticleIdList": ["2567594"]}, {"Citation": "Proc Natl Acad Sci U S A. 1987 Dec;84(24):9265-9", "ArticleIdList": ["2827174"]}, {"Citation": "J Pharmacol Exp Ther. 1986 May;237(2):529-38", "ArticleIdList": ["3009791"]}, {"Citation": "Br J Pharmacol. 1986 Jun;88(2):411-5", "ArticleIdList": ["3089351"]}, {"Citation": "Br J Pharmacol. 1987 Nov;92(3):639-46", "ArticleIdList": ["3322462"]}, {"Citation": "J Biol Chem. 1988 Feb 15;263(5):2316-23", "ArticleIdList": ["3339013"]}, {"Citation": "J Clin Invest. 1988 Jun;81(6):1752-8", "ArticleIdList": ["3384950"]}, {"Citation": "Nature. 1987 Jun 11-17;327(6122):524-6", "ArticleIdList": ["3495737"]}, {"Citation": "Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):444-8", "ArticleIdList": ["1346070"]}]}], "History": [{"Year": "1992", "Month": "8", "Day": "15"}, {"Year": "1992", "Month": "8", "Day": "15", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "8", "Day": "15", "Hour": "0", "Minute": "0"}, {"Year": "1993", "Month": "2", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1502182", "PMC49773", "10.1073/pnas.89.16.7674"]}}], "PubmedBookArticle": []}